Aldeyra Therapeutics (NASDAQ: ALDX) disclosed the following in a U.S. SEC filing on Friday:Item ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE